ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,138Medicare Part D Prescriptions Filled, Including Refills

Rank: 139 out of 2094

$771K Total Retail Price of All Prescriptions

Rank: 195 out of 2094

366 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 366 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 7,604 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 588 342 1 1
OMEPRAZOLE 441 280 2 4
DIOVAN 309 235 3 13
AMLODIPINE BESYLATE 293 226 4 2
LEVOTHYROXINE SODIUM 246 200 5 3
ENALAPRIL MALEATE 239 168 6 25
FUROSEMIDE 232 189 7 6
METOPROLOL TARTRATE 224 145 8 10
METFORMIN HCL 219 130 9 8
ADVAIR DISKUS 209 124 10 36
GABAPENTIN 208 113 11 23
JANUVIA 190 127 12 35
METOPROLOL SUCCINATE 173 142 13 9
DIOVAN HCT 173 147 13 28
TRAMADOL HCL 167 109 15 33
WARFARIN SODIUM 165 106 16 11
CLOPIDOGREL 160 120 17 22
ALENDRONATE SODIUM 157 133 18 30
ATORVASTATIN CALCIUM 151 109 19 5
LISINOPRIL 149 109 20 7
NAPROXEN 149 91 20 84
PROAIR HFA 137 85 22 45
LEVOFLOXACIN 133 92 23 70
FAMOTIDINE 128 102 24 34
NEXIUM 124 61 25 16
JANUMET 101 51 26 86
POTASSIUM CHLORIDE 99 92 27 24
FLUTICASONE PROPIONATE 99 55 27 41
LANTUS 95 66 29 66
CRESTOR 92 58 30 15
NIFEDIPINE ER 91 65 31 96
AMOXICILLIN 90 54 32 147
FENOFIBRATE 90 42 32 104
CYMBALTA 86 59 34 61
HYDROCHLOROTHIAZIDE 85 48 35 12
ACTOS 81 46 36 112
CARVEDILOL 79 59 37 19
LEVOCETIRIZINE DIHYDROCHLORIDE 79 46 37 169
GLIMEPIRIDE 79 61 37 31
PANTOPRAZOLE SODIUM 77 55 40 37
MELOXICAM 75 65 41 49
ZETIA 75 54 41 79
VENTOLIN HFA 74 28 43 132
ATENOLOL 72 59 44 21
OXYCODONE-ACETAMINOPHEN 70 24 S2 45 40
PLAVIX 69 55 46 38
LOSARTAN POTASSIUM 66 60 47 17
TAMSULOSIN HCL 64 56 48 29
HYDROMORPHONE HCL 64 0 S2 48 225
IBUPROFEN 61 41 50 73
LIPITOR 60 58 51 39
SINGULAIR 59 36 52 64
LACTULOSE 58 45 53 65
ALBUTEROL SULFATE 57 57 54 90
DIGOXIN 57 48 54 51
DONEPEZIL HCL 56 53 56 20
DEXILANT 55 49 57 124
FLUOCINONIDE 53 43 58 238
PREDNISONE 53 43 58 54
DICLOFENAC SODIUM 52 23 60 168
CLONIDINE HCL 52 31 60 62
MONTELUKAST SODIUM 50 26 62 128
NOVOLOG 50 44 62 116
MECLIZINE HCL 50 38 62 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.